CPS by CPhA is a clinical drug information resource for Canadian health care practitioners, offering monographs and therapeutic algorithms via subscription on iOS.
The App DNA
What makes this app unique?
The platform removes the cognitive cost of verifying drug information against Health Canada standards during patient consultations.
For Health care practitioners requiring evidence-based drug information and clinical decision support at the point-of-care.
What does it look like?
Key features
Database of thousands of drug, vaccine, and medical device monographs approved by Health Canada.
Evidence-based therapeutic guidance and condition-based drug tables.
Integrated tools for clinical calculations at the point-of-care.
How much does it cost?
Subscription model segments users by clinical depth, gating advanced therapeutic algorithms behind the Full Access tier.
Velocity
Maintenance developmentperformanceShow more...
Development momentum is currently in a maintenance state, with only one release recorded in the analyzed window. The latest version, released 159 days ago, provided only minor enhancements and bug fixes. There is no evidence of new features or live operations, indicating a focus on stability rather than active product evolution.
Who built it?
Canadian Pharmacists Association (CPhA)
2 apps tracked · Medical
CPS by CPhAUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for CPS by CPhA
How's the Medical market?
CPS by CPhA maintains a niche position as the Canadian standard for drug monographs, yet the 1-star rating across the current user base suggests the platform is failing to meet professional expectations.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for CPS by CPhA
Where is it heading?
The clinical reference market is shifting toward high-frequency update cycles to match evolving therapeutic guidelines. CPS by CPhA's current maintenance-only posture risks professional churn, as the 1-star rating suggests the platform is no longer meeting the reliability requirements of its target audience.
- The 159-day gap since the latest release indicates a maintenance-only posture that leaves the app vulnerable to more agile clinical reference tools.
The SWOT
- Health Canada-approved monograph database creates a regulatory-backed barrier to entry
- Offline-first access for critical drug tables would improve utility in clinical settings
Next best moves
Audit stability in the latest release because the 1-star rating indicates critical usability failures → restore professional trust
The counter-intuitive read
The reliance on Health Canada-approved content is a…
Read the full takeSince the last report: The emergence of a 1-star rating and associated technical instability has shifted the platform's outlook from neutral to declining. This change highlights a critical gap between the app's regulatory-backed content and its current functional reliability.
Bottom line
Prioritizing a stability-focused release cycle would address the critical usability failures currently driving the 1-star rating, which is the primary barrier to professional adoption.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated